Sign in

CIK 0000078003

  • Large accelerated filer
Ticker
PFE
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
135315170
Phone
+1 212-733-2323
Business address
66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192
Former names
PFIZER INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-09-12 Dolsten Mikael President R&D Returned to the company · Stock Appreciation Rights −137,760 0
2024-09-12 Dolsten Mikael President R&D Grant or award · Stock Appreciation Rights +137,760 137,760
2024-09-12 Dolsten Mikael President R&D Returned to the company · Stock Appreciation Rights −126,794 0
2024-09-12 Dolsten Mikael President R&D Grant or award · Stock Appreciation Rights +126,794 126,794
2024-02-28 Dolsten Mikael President R&D Shares withheld for taxes −21,437 $27.04 $580K 321,729
2024-02-27 Dolsten Mikael President R&D Grant or award · Stock Appreciation Rights +214,880 214,880
2024-02-27 Dolsten Mikael President R&D Grant or award · Stock Appreciation Rights +189,867 189,867
2024-02-23 Dolsten Mikael President R&D Shares withheld for taxes −24,822 $27.76 $689K 343,166

Page 1 of 1 · 8 trades